| Dr William A Boller Iii, MD | |
|
1 Wahoo Ave, Groton, CT 06349-2324 | |
| (860) 694-2377 | |
| (860) 694-2590 |
| Full Name | Dr William A Boller Iii |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1 Wahoo Ave, Groton, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972730380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101250100 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charles A Dean Memorial Hospital | Greenville, ME | Hospital |
| Mayo Regional Hospital | Dover foxcroft, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charles A. Dean Memorial Hospital | 1557279031 | 19 |
News Archive
Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
The Healthy Diet Index developed by Finnish nutrition experts facilitates the assessment of diet quality. Its effectiveness was demonstrated in a recently published study.
Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 6 days ago
| Entity Name | Charles A. Dean Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659388213 PECOS PAC ID: 1557279031 Enrollment ID: O20100608000349 |
News Archive
Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
The Healthy Diet Index developed by Finnish nutrition experts facilitates the assessment of diet quality. Its effectiveness was demonstrated in a recently published study.
Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 6 days ago
| Entity Name | Mrh Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558319103 PECOS PAC ID: 1355770892 Enrollment ID: O20200803002384 |
News Archive
Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
The Healthy Diet Index developed by Finnish nutrition experts facilitates the assessment of diet quality. Its effectiveness was demonstrated in a recently published study.
Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William A Boller Iii, MD 1 Wahoo Ave, Groton, CT 06349-2324 Ph: (860) 694-2377 | Dr William A Boller Iii, MD 1 Wahoo Ave, Groton, CT 06349-2324 Ph: (860) 694-2377 |
News Archive
Today's headlines include reports that the Obama administration will extend the deadline for signing up for insurance through healthcare.gov.
Children who have a high risk of developing type 2 diabetes might be identified earlier by way of tell-tale genetic indicators known as biomarkers. Some of those new biomarkers might be pinpointed in research led by Nancy F. Butte and funded by the U.S. Department of Agriculture (USDA) and the U.S. Department of Health and Human Service's National Institutes of Health.
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.
The Healthy Diet Index developed by Finnish nutrition experts facilitates the assessment of diet quality. Its effectiveness was demonstrated in a recently published study.
Australian general practitioners often treat patients with low back pain in a manner that does not appear to match the care endorsed by international clinical guidelines, according to a report in the February 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
› Verified 6 days ago
Paul David Seeman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Route 12 Bldg 449 Professional Affairs, Naval Ambulatory Care Center, Groton, CT 06349 Phone: 860-694-2377 Fax: 860-694-2590 | |
Dr. John William Dorunda, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Wahoo Ave, Nbhc Groton, Groton, CT 06340 Phone: 860-694-4123 Fax: 860-694-1330 | |
Matthew Martin, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 904-542-7300 | |
Dr. Jennifer Donahue, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 Poheganut Dr, Groton, CT 06340 Phone: 860-448-6303 Fax: 860-448-9678 | |
Dr. Ryan Christopher Bartle, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Wahoo Ave, Groton, CT 06349 Phone: 860-235-6362 | |
Dr. Laura Anne Watts, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 Poheganut Dr, Groton, CT 06340 Phone: 860-448-6303 Fax: 860-448-9678 | |
John Christopher Daniel, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Trout Ave Bldg 141, Naval Submarine Medical Research Laboratory, Groton, CT 06349 Phone: 860-694-2377 Fax: 860-694-3590 |